The success of Sildenafil initially sparked a boom for the drug industry, but recent developments present a complicated scenario for shareholders. Generic competitors are reducing revenue, and continued legal battles https://kallumaedk559182.blog-ezine.com/41738935/sildenafil-and-big-pharma-a-risky-investment